A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors

Jens Voortman; Egbert F. Smit; Richard Honeywell; Bart C. Kuenen; Godefridus J. Peters; Helgi van de Velde; Giuseppe Giaccone

doi:10.1158/1078-0432.CCR-07-0061

A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors

Jens Voortman
, Egbert F. Smit
, Richard Honeywell
, Bart C. Kuenen
, Godefridus J. Peters
, Helgi van de Velde
, Giuseppe Giaccone

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	3642-3651
Journal	Clinical cancer research
Volume	13
Issue number	12
DOIs	https://doi.org/10.1158/1078-0432.CCR-07-0061
Publication status	Published - 15 Jun 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1158/1078-0432.CCR-07-0061

Cite this

Voortman, J., Smit, E. F., Honeywell, R., Kuenen, B. C., Peters, G. J., de Velde, H. V., & Giaccone, G. (2007). A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors. Clinical cancer research, 13(12), 3642-3651. https://doi.org/10.1158/1078-0432.CCR-07-0061

@article{5b30ef6d84b742929672abe10e81a88a,

title = "A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors",

author = "Jens Voortman and Smit, \{Egbert F.\} and Richard Honeywell and Kuenen, \{Bart C.\} and Peters, \{Godefridus J.\} and \{de Velde\}, \{Helgi van\} and Giuseppe Giaccone",

year = "2007",

month = jun,

day = "15",

doi = "10.1158/1078-0432.CCR-07-0061",

language = "English",

volume = "13",

pages = "3642--3651",

journal = "Clinical cancer research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "12",

}

Voortman, J, Smit, EF, Honeywell, R, Kuenen, BC, Peters, GJ, de Velde, HV & Giaccone, G 2007, 'A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors', Clinical cancer research, vol. 13, no. 12, pp. 3642-3651. https://doi.org/10.1158/1078-0432.CCR-07-0061

A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors. / Voortman, Jens; Smit, Egbert F.; Honeywell, Richard et al.
In: Clinical cancer research, Vol. 13, No. 12, 15.06.2007, p. 3642-3651.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors

AU - Voortman, Jens

AU - Smit, Egbert F.

AU - Honeywell, Richard

AU - Kuenen, Bart C.

AU - Peters, Godefridus J.

AU - de Velde, Helgi van

AU - Giaccone, Giuseppe

PY - 2007/6/15

Y1 - 2007/6/15

U2 - 10.1158/1078-0432.CCR-07-0061

DO - 10.1158/1078-0432.CCR-07-0061

M3 - Article

SN - 1078-0432

VL - 13

SP - 3642

EP - 3651

JO - Clinical cancer research

JF - Clinical cancer research

IS - 12

ER -